|Mr. Mark A. Augusti||CEO, Pres & Director||770.08k||N/A||1966|
|Mr. Paul S. Weiner CPA||Consultant||418.3k||N/A||1964|
|Mr. Frederick W. Driscoll||Interim Chief Financial Officer||N/A||N/A||1951|
|Mr. Ed Kilgallen||VP of Operations||N/A||N/A||N/A|
|Ms. Erin Henry||Interim Principal Accounting Officer & Corp. Controller||N/A||N/A||1984|
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.
Conformis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.